Use of anti-cd1 antibodies for the modulation of immune responses

The invention provides methods for the administration of an anti-CD1 antibody for the treatment or prevention of a variety of disorders, such as autoimmune disease, viral infection, bacterial infection, parasitic infection, infection by a eukaryotic pathogen, allergy, asthma, inflammatory condition,...

Full description

Saved in:
Bibliographic Details
Main Authors STEVEN P. BALK, SIMON C. YUE, MARK A. EXLEY
Format Patent
LanguageEnglish
Published 17.11.2003
Edition7
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

Abstract The invention provides methods for the administration of an anti-CD1 antibody for the treatment or prevention of a variety of disorders, such as autoimmune disease, viral infection, bacterial infection, parasitic infection, infection by a eukaryotic pathogen, allergy, asthma, inflammatory condition, graft versus host disease, graft rejection, immunodeficiency disease, spontaneous abortion, pregnancy, and cancer.
AbstractList The invention provides methods for the administration of an anti-CD1 antibody for the treatment or prevention of a variety of disorders, such as autoimmune disease, viral infection, bacterial infection, parasitic infection, infection by a eukaryotic pathogen, allergy, asthma, inflammatory condition, graft versus host disease, graft rejection, immunodeficiency disease, spontaneous abortion, pregnancy, and cancer.
Author STEVEN P. BALK
SIMON C. YUE
MARK A. EXLEY
Author_xml – fullname: STEVEN P. BALK
– fullname: SIMON C. YUE
– fullname: MARK A. EXLEY
BookMark eNrjYmDJy89L5WRwDC1OVchPU0jMK8nUTU4xBDOS8lMyU4sV0vKLFEoyUhVy81NKcxJLMvPzQCozc3NL81IVilKLC_LzilOLeRhY0xJzilN5oTQ3g7Kba4izh25qQX48UFFicmpeakm8Y6iRgYGxkbGJiYmxo4UxcaoAmPsz0Q
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 7
ExternalDocumentID AU2003234443A8
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2003234443A83
IEDL.DBID EVB
IngestDate Fri Jul 19 13:06:34 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2003234443A83
Notes Application Number: AU20030234443
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20031117&DB=EPODOC&CC=AU&NR=2003234443A8
ParticipantIDs epo_espacenet_AU2003234443A8
PublicationCentury 2000
PublicationDate 20031117
PublicationDateYYYYMMDD 2003-11-17
PublicationDate_xml – month: 11
  year: 2003
  text: 20031117
  day: 17
PublicationDecade 2000
PublicationYear 2003
RelatedCompanies BETH ISRAEL DEACONESS MEDICAL CENTER
RelatedCompanies_xml – name: BETH ISRAEL DEACONESS MEDICAL CENTER
Score 2.5813885
Snippet The invention provides methods for the administration of an anti-CD1 antibody for the treatment or prevention of a variety of disorders, such as autoimmune...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Title Use of anti-cd1 antibodies for the modulation of immune responses
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20031117&DB=EPODOC&locale=&CC=AU&NR=2003234443A8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp-LHlIDSt2K7pl8PQ7p2Ywj7QFbZ2zAfhYK2Y63473vJNt3TXsKRC0cS-OUuuY8APNHACbinKreq3A_qUttkgnpmwH3JM9figa6uPxp7w5S-zt15Az63uTC6TuiPLo6IiOKI91qf18v_R6xEx1ZWzyzHrvJlMOsmxvZ27CB0fSPpdfvTSTKJjTjGm6QxftO8jkMpdaLgAA7RkPYVHvrvPZWXstxVKoMzOJqivKI-h4YsWnASb_9ea8HxaOPyRnKDvuoCorSSpMwIbkZucmFrgpUqDpCg7UnQliNfpdh8yKVG5ir7Q5LVOhBWVpfwOOjP4qGJc1n8LX0RpbsTd66gWZSFvAYiRMi5LzJmhYxi80E7FlNOPi-zQik6N9DeJ-l2P_sOTtdBa7Zp-21o1qtveY_Kt2YPes9-Adh3h00
link.rule.ids 230,309,783,888,25576,76882
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8JhTnG86FT-mBpS-Fds1a7uHIVs_mLovZJO9DfNRGGg71op_30u26Z72Eo4kHJfA5e5yXwAP1Hd87qrKrSr3gzaobTJBXdPnnuRJw-K-rq7fH7jdCX2ZNqYl-Nzkwug6oT-6OCJyFEd-L_R7vfj_xAp1bGX-yOY4lT3F41ZobKxjB1nXM8JOKxoNw2FgBAFaksbgTa_VHUqp0_b3YB-VbF_1O4jeOyovZbEtVOJjOBghvrQ4gZJMq1AJNr3XqnDYX7u8EVxzX34K7UkuSZYQvIy5yYWtAZapOECCuidBXY58ZWLdkEvtnKvsD0mWq0BYmZ_BfRyNg66JtMz-jj5rT7YJd86hnGapvAAiRJNzTyTMajKKwwetW0w5-dzEakpRv4TaLkxXu5fvoNId93uz3vPg9RqOVgFstml7NSgXy295g4K4YLf6_n4BWRaKPQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Use+of+anti-cd1+antibodies+for+the+modulation+of+immune+responses&rft.inventor=STEVEN+P.+BALK&rft.inventor=SIMON+C.+YUE&rft.inventor=MARK+A.+EXLEY&rft.date=2003-11-17&rft.externalDBID=A8&rft.externalDocID=AU2003234443A8